darapladib
Showing 1 - 10 of 10
Atherosclerosis Trial in Baltimore (Darapladib, Diltiazem)
Completed
- Atherosclerosis
- Darapladib
- Diltiazem
-
Baltimore, MarylandGSK Investigational Site
Jul 10, 2017
Atherosclerosis Trial in Miami, Orlando (darapladib)
Completed
- Atherosclerosis
- darapladib
-
Miami, Florida
- +1 more
Jul 24, 2017
Atherosclerosis Trial in Baltimore (Darapladib, Midazolam)
Completed
- Atherosclerosis
- Darapladib
- Midazolam
-
Baltimore, MarylandGSK Investigational Site
May 12, 2017
Atherosclerosis Trial in Cambridge (Darapladib)
Completed
- Atherosclerosis
- Darapladib
-
Cambridge, United KingdomGSK Investigational Site
May 12, 2017
Endothelial Dysfunction Trial in Rochester (darapladib, )
Completed
- Endothelial Dysfunction
- darapladib
- placebo
-
Rochester, MinnesotaMayo Clinic
Mar 22, 2017
Atherosclerosis Trial in Tacoma (darapladib)
Completed
- Atherosclerosis
- darapladib
-
Tacoma, WashingtonGSK Investigational Site
Nov 15, 2016
Atherosclerosis Trial in Evansville (Darapladib)
Completed
- Atherosclerosis
- Darapladib
-
Evansville, IndianaGSK Investigational Site
Oct 27, 2016
Retinopathy, Diabetic Trial in Worldwide (darapladib, )
Completed
- Retinopathy, Diabetic
- darapladib
- placebo
-
Parramatta, New South Wales, Australia
- +15 more
Nov 18, 2016
SB-480848 in Major Adverse Cardiovascular Events - Integrated
Completed
- Coronary Heart Disease
- darapladib
- placebo
- (no location specified)
Oct 30, 2014